| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |